Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q1 2023 Earnings Presentation
9 slides from Phibro Animal Health's earnings presentation, Nov 10, 2022
Slide 1: Phibro Animal Health Corporation Webcast and Conference Call
Phibro Animal Health Corporation Webcast and Conference Call November 10, 2022 Financial Results U.S. toll-free +1.888.330.2022 Fiscal Year 2023 International toll +1.365.977.0051 First Quarter Ended September 30, 2022 Conference ID: [3927884] 1 November 10, 2022 Webcast & Conference Call
Slide 2: Important Information
Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties, including with respect to future debt and leverage levels. All statements other than statements of historical or current
Slide 3: Key Themes
Key Themes First Quarter Macro-economic and Anticipating further Adjusting projections to Continued strong demand operational challenges benefits from strategic reflect higher interest for our product portfolio persist investments expense & taxes Year-over-year net sales Supply chain disruptions are
Slide 4: Financial Performance - Consolidated
Financial Performance - Consolidated First Quarter, Year-on-Year comparison $ in millions, except per share data Net Sales – increased $17.9 million, or 8%, increase driven by improvement in both the Animal Health and Mineral Nutrition segments, offset by a slight decline in our Performance Produc
Slide 5: Financial Performance – Animal Health
Financial Performance – Animal Health First Quarter, Year-on-Year comparison $ in millions YOY Net Sales – increased $13.9 million, or 10% Q1 %∆ MFAs and other - Increased $9.0 million, or 11%, primarily driven by Animal Health increased sales of processing aids used in the ethanol fermentation
Slide 6: Financial Performance – Other Segments
Financial Performance – Other Segments First Quarter, Year-on-Year comparison $ in millions YOY Mineral Nutrition Q1 %∆ - Net sales increased $5.2 million, or 10%, primarily driven by Mineral Nutrition higher average selling prices of trace minerals correlated with the movement of the underlying r
Slide 7: Key Capitalization Metrics
Key Capitalization Metrics First Quarter Highlights -$21 million of trailing 12-month free cash flow; Free Cash Flow operating cash flow of $17 million less capital expenditures of $38 million1 4.2x gross leverage ratio; $468 million total debt Leverage November 10, 2022 / $111 million trailing 12-m
Slide 8: Financial Guidance
Financial Guidance Fiscal Year 2023 $ in millions, except earnings per share (EPS) data FY 2023 The Company reiterated guidance for Net Full Year Guidance sales and Adjusted EBITDA. Previous Updated Given the unfavorable impact of higher Low High Low High interest rates and debt outstanding, and
Slide 9: © 2022 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy
© 2022 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; and any other Phibro brand or brands shown herein are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates. Any other trademark that